Related references
Note: Only part of the references are listed.Secretory leukocyte protease inhibitor regulates nerve reflex-mediated skin barrier function in psoriasis
P. Kwiecinska et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)
MRGPRX2 Is the Codeine Receptor of Human Skin Mast Cells: Desensitization through β-Arrestin and Lack of Correlation with the FcεRI Pathway
Magda Babina et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Nonpeptidergic neurons suppress mast cells via glutamate to maintain skin homeostasis
Shiqun Zhang et al.
CELL (2021)
Differences in Staining for Neutrophil Elastase and its Controlling Inhibitor SLPI Reveal Heterogeneity among Neutrophils in Psoriasis
Joanna Skrzeczynska-Moncznik et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Inflammation-induced IgE promotes epithelial hyperplasia and tumour growth
Mark David Hayes et al.
ELIFE (2020)
Activation of Mast-Cell-Expressed Mas-Related G-Protein-Coupled Receptors Drives Non-histaminergic Itch
James Meixiong et al.
IMMUNITY (2019)
MRGPR-mediated activation of local mast cells clears cutaneous bacterial infection and protects against reinfection
Mohammad Arifuzzaman et al.
SCIENCE ADVANCES (2019)
Skin microbiome promotes mast cell maturation by triggering stem cell factor production in keratinocytes
Zhenping Wang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Identification of Secretory Leukoprotease Inhibitor As an Endogenous Negative Regulator in Allergic Effector Cells
Shintaro Matsuba et al.
FRONTIERS IN IMMUNOLOGY (2017)
Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response
Monika Majchrzak-Gorecka et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Different activation signals induce distinct mast cell degranulation strategies
Nicolas Gaudenzio et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps
Katarzyna Zabieglo et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Secretory Leukocyte Protease Inhibitor Reverses Inhibition by CNS Myelin, Promotes Regeneration in the Optic Nerve, and Suppresses Expression of the Transforming Growth Factor-β Signaling Protein Smad2
Sari S. Hannila et al.
JOURNAL OF NEUROSCIENCE (2013)
Secretory Leukocyte Proteinase Inhibitor-Competent DNA Deposits Are Potent Stimulators of Plasmacytoid Dendritic Cells: Implication for Psoriasis
Joanna Skrzeczynska-Moncznik et al.
JOURNAL OF IMMUNOLOGY (2012)
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
Leslie van der Fits et al.
JOURNAL OF IMMUNOLOGY (2009)
Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice
Valeska Heib et al.
BLOOD (2007)
Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding
CC Taggart et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis
GJ de Jongh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Conversion of proepithelin to epithelins: Roles of SLPI and elastase in host defense and wound repair
J Zhu et al.
CELL (2002)
Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IκBα degradation without affecting phosphorylation or ubiquitination
CC Taggart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing
GS Ashcroft et al.
NATURE MEDICINE (2000)
Share Paper
